Priority Date: 01.06.16 (EP 20160172487)

USE OF ECM BIOMARKERS FOR THE DETERMINING THE TREATMENT ONSET WITH NINTEDANIB AND PIRFENIDONE

  • Application ID: EP17726643
  • Status: Request for examination was made

Applicant

Attorney

no operation time available
2 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Boehringer Ingelheim GmbH is specialized in A61. Boehringer Ingelheim GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 01.06.2016 - Priority Date (EP 20160172487)
  • 07.12.2017 - Publication A1 (WO2017207643)
  • 10.04.2019 - Publication A1 (EP3463353)

IPC Classification